logo image
search icon
Base Editing Market

Base Editing Market Size, Share & Trends Analysis Report by Product (Platform, Reagents & Kits, Plasmids, Base Editing Libraries), Service (gRNA Design, Cell Line Engineering), Type, Targeted base (Cytosine, Adenine), Application (Drug Discovery, Agriculture, Veterinary), By Region, And By Segment Forecasts, 2024-2031

Report ID : 2619 | Published : 2024-07-31 | Pages: 180 | Format: PDF/EXCEL/Power BI Dashbord

The Base Editing Market Size is valued at USD 273.1 Mn in 2023 and is predicted to reach USD 904.8 Mn by the year 2031 at a 16.4% CAGR during the forecast period for 2024-2031.

base editing

Base editing refers to the methods and instruments that radically alter an existing biological genomic instruction by making incredibly precise modifications to DNA sequences of genes. The scientific and medical sectors are developing associations to pool data and assets in order to expedite the creation and implementation of base editing techniques since they recognize the attractiveness of this innovation.

Through these alliances, the industry is advanced, and creativity is encouraged by the sharing of economic expenditures, availability of a variety of investigation skills, and integration of expertise. As a whole, the base editing industry advances because of cooperative initiatives, which also improve the capacity to handle difficulties pertaining to ethical concerns with the instrument and negotiate regulatory obstacles. The COVID-19 epidemic has also had a major effect on the growth of the market for tests for base editing. The ability of these advances to support early diagnosis and customized treatment has improved patient outcomes.

However, regulations that are too stringent to ensure the health and safety of the base edit the product's lack of capacity to prevent fog in conditions with significant temperature swings or elevated humidity. The demand for base editing carries the risk of adverse impacts or accidental genetic alterations. The safety and specificity of base editing tools must be guaranteed before they can be utilized extensively. The potential for unintentional genomic alterations can impede regulatory approvals and market acceptance. Maintaining investigations are focused on advancing base editing techniques to decrease unwanted consequences and enhance risk depicts.  

Competitive Landscape

Some Major Key Players In The Base Editing Market:

  • Addgene
  • Base Therapeutics
  • Beam Therapeutics
  • Bio Palette Co., Ltd
  • Cellectis
  • Creative Biogene
  • Danaher Corporation
  • EdiGene, Inc.
  • ElevateBio
  • GenKOre
  • GenScript
  • Horizon Discovery Group plc.
  • HuidaGene Therapeutics
  • Intellia Therapeutics, Inc.
  • KromaTiD, Inc.
  • Maravai LifeSciences
  • Merck KGaA
  • Pairwise
  • ProQR Therapeutics
  • QI-Biodesign
  • Revvity
  • Shape TX
  • Synthego
  • Verve Therapeutics, Inc.
  • Other Market Players

Market Segmentation:

The base editing market is segmented based on type, product & service, targeted base, application, and end user. As per the product, the market is segmented into platform, reagents & kits, plasmids and base editing libraries. By service, the market is segmented into gRNA design and cell line engineering. By type, the market is segmented into DNA-base editing and RNA-base editing. By targeted base, the market is segmented into cytosine and adenine. The application segment comprises drug discovery, agriculture, and veterinary. By end user, the market is segmented into academic & research institutes, pharmaceutical & biotechnology companies, and contract research organizations.

Based on the Type, the RNA Base Editing Base Editing Market Segment Is Accounted As A Major Contributor To The Base Editing Market.

The RNA-based editing category is expected to hold a major global market share in 2023. RNA base editing permits changes to be made without affecting the fundamental Genome. This kind of base editing presents special benefits in several medical and research settings, and it shows interest in situations where short-term modifications are acceptable.

Pharmaceutical & Biotechnology Companies' Segment to Witness Growth at a Rapid Rate.

The pharmaceutical & biotechnology companies industry uses the majority of base editing because these businesses are presently investigating base editing as a means of creating cutting-edge treatments. To treat a range of genetic illnesses and provide personalized healthcare, they are utilizing base editing technologies. To use cutting-edge gene editing technologies to produce novel medicines for a range of illnesses, they are increasing their research and development expenditures, especially in countries.

In The Region, The North American Base Editing Market Holds A Significant Revenue Share.

The North American base editing market is expected to record the maximum market share in the near future. It can be attributed to the substantial expansion of the biomedical and medicine sectors, as well as the rising cost of development. Because there are so many top-tier industrial institutions and pharmaceutical companies in the US, growth in this country is predicted to be the greatest. In addition, Asia Pacific (APAC) is estimated to grow rapidly in the global base editing market due to a growing agriculture industry, rising knowledge of hereditary abnormalities, and growing medical expenses. Government-sponsored initiatives that fund genetic investigation, innovation transfers, and cooperation all increase the area's possibility of market growth.

Recent Developments:

  • In Sept 2023, Revvity, Inc. introduces Pin-point™ base editing platform reagents, enabling researchers to use advanced gene editing techniques in their preclinical labs. Base editing is a significant advancement in CRISPR gene editing, allowing for complex and safe multi-gene editing, which can lead to improved functional genomics insights for drug development, as well as streamlining cell line and cell therapy development and manufacturing. The Pin-point platform is one of the few established base editing technologies presently in use in clinical settings, serving as both a discovery and treatment tool.
  • In Aug 2023, Pairwise and Bayer recently entered into a new five-year, multi-million dollar deal that specifically targets advancements in short-stature maize. Pairwise, a prominent food and agriculture company, is known for introducing the first gene-edited food to the U.S. market. This new program employed Pairwise's Fulcrum™ platform and built upon the achievements of the firms' previous five-year partnership in the cultivation of corn, soy, wheat, cotton, and canola. Annual partnership for the cultivation of corn, soy, wheat, cotton, and canola. 

Base Editing Market Report Scope

Report Attribute

Specifications

Market Size Value In 2023

USD 273.1 Mn

Revenue Forecast In 2031

USD 904.8 Mn

Growth Rate CAGR

CAGR of 16.4% from 2024 to 2031

Quantitative Units

Representation of revenue in US$ Mn and CAGR from 2024 to 2031

Historic Year

2019 to 2023

Forecast Year

2024-2031

Report Coverage

The forecast of revenue, the position of the company, the competitive market structure, growth prospects, and trends

Segments Covered

By Type, Product & Service, Targeted Base, Application, And End User

Regional Scope

North America; Europe; Asia Pacific; Latin America; Middle East & Africa

Country Scope

U.S.; Canada; U.K.; Germany; China; India; Japan; Brazil; Mexico; France; Italy; Spain; Southeast Asia; South Korea

Competitive Landscape

Danaher Corporation, Merck KgaA, Revvity, Maravai LifeSciences, GenScript, Beam Therapeutics, Intellia Therapeutics, Inc., Cellectis, Bio Palette Co., Ltd, Addgene, Synthego, EdiGene, Inc. and Others

Customization Scope

Free customization report with the procurement of the report and modifications to the regional and segment scope. Particular Geographic competitive landscape.

Pricing And Available Payment Methods

Explore pricing alternatives that are customized to your particular study requirements.

Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions

Chapter 2. Executive Summary

Chapter 3. Global Base Editing Market Snapshot

Chapter 4. Global Base Editing Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Drivers
4.3. Challenges
4.4. Trends
4.5. Investment and Funding Analysis
4.6. Industry Analysis – Porter’s Five Forces Analysis
4.7. Competitive Landscape & Market Share Analysis
4.8. Impact of Covid-19 Analysis

Chapter 5. Market Segmentation 1: By Product & Service Estimates & Trend Analysis
5.1. By Product & Service & Market Share, 2023 & 2031
5.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2019 to 2031 for the following By Product & Service:

5.2.1. Product

5.2.1.1. Platform
5.2.1.2. Kits & Reagents
5.2.1.3. Plasmids
5.2.1.4. Base Editing Libraries

5.2.2. Services

5.2.2.1. gRNA Design
5.2.2.2. Cell line engineering
5.2.2.3. Other Services

Chapter 6. Market Segmentation 2: By Type Estimates & Trend Analysis
6.1. By Type & Market Share, 2023 & 2031
6.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2019 to 2031 for the following By Type:

6.2.1. DNA base editing
6.2.2. RNA base editing

Chapter 7. Market Segmentation 3: By Targeted base Estimates & Trend Analysis
7.1. By Targeted base & Market Share, 2023 & 2031
7.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2019 to 2031 for the following By Targeted base:

7.2.1. Cytosine base editing
7.2.2. Adenine base editing

Chapter 8. Market Segmentation 4: By Application Estimates & Trend Analysis
8.1. By Application & Market Share, 2023 & 2031
8.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2019 to 2031 for the following By Application:

8.2.1. Drug Discovery & Development
8.2.2. Agriculture
8.2.3. Veterinary

Chapter 9. Market Segmentation 5: by End User Estimates & Trend Analysis
9.1. by End User & Market Share, 2023 & 2031
9.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2019 to 2031 for the following by End User:

9.2.1. Pharmaceutical & Biotechnology Companies
9.2.2. Academic & Research Institutes
9.2.3. Contract Research Organizations

Chapter 10. Base Editing Market Segmentation 6: Regional Estimates & Trend Analysis

10.1. North America
10.1.1. North America Base Editing Market Revenue (US$ Million) Estimates and Forecasts by Product & Service, 2024-2031
10.1.2. North America Base Editing Market Revenue (US$ Million) Estimates and Forecasts by End User, 2024-2031
10.1.3. North America Base Editing Market Revenue (US$ Million) Estimates and Forecasts by Type, 2024-2031
10.1.4. North America Base Editing Market Revenue (US$ Million) Estimates and Forecasts by Targeted base, 2024-2031
10.1.5. North America Base Editing Market Revenue (US$ Million) Estimates and Forecasts by Application, 2024-2031
10.1.6. North America Base Editing Market Revenue (US$ Million) Estimates and Forecasts by country, 2024-2031

10.2. Europe
10.2.1. Europe Base Editing Market Revenue (US$ Million) Estimates and Forecasts by Product & Service, 2024-2031
10.2.2. Europe Base Editing Market Revenue (US$ Million) Estimates and Forecasts by End User, 2024-2031
10.2.3. Europe Base Editing Market Revenue (US$ Million) Estimates and Forecasts by Type, 2024-2031
10.2.4. Europe Base Editing Market Revenue (US$ Million) Estimates and Forecasts by Targeted base, 2024-2031
10.2.5. Europe Base Editing Market Revenue (US$ Million) Estimates and Forecasts by Application, 2024-2031
10.2.6. Europe Base Editing Market Revenue (US$ Million) Estimates and Forecasts by country, 2024-2031

10.3. Asia Pacific
10.3.1. Asia Pacific Base Editing Market Revenue (US$ Million) Estimates and Forecasts by Product & Service, 2024-2031
10.3.2. Asia Pacific Base Editing Market Revenue (US$ Million) Estimates and Forecasts by End User, 2024-2031
10.3.3. Asia Pacific Base Editing Market Revenue (US$ Million) Estimates and Forecasts by Type, 2024-2031
10.3.4. Asia Pacific Base Editing Market Revenue (US$ Million) Estimates and Forecasts by Targeted base, 2024-2031
10.3.5. Asia Pacific Base Editing Market Revenue (US$ Million) Estimates and Forecasts by Application, 2024-2031
10.3.6. Asia Pacific Base Editing Market Revenue (US$ Million) Estimates and Forecasts by country, 2024-2031

10.4. Latin America
10.4.1. Asia Pacific Base Editing Market Revenue (US$ Million) Estimates and Forecasts by Product & Service, 2024-2031
10.4.2. Asia Pacific Base Editing Market Revenue (US$ Million) Estimates and Forecasts by End User, 2024-2031
10.4.3. Latin America Base Editing Market Revenue (US$ Million) Estimates and Forecasts by Type, 2024-2031
10.4.4. Latin America Base Editing Market Revenue (US$ Million) Estimates and Forecasts by Targeted base, 2024-2031
10.4.5. Latin America Base Editing Market Revenue (US$ Million) Estimates and Forecasts by Application, 2024-2031
10.4.6. Latin America Base Editing Market Revenue (US$ Million) Estimates and Forecasts by country, 2024-2031

10.5. Middle East & Africa
10.5.1. Middle East & Africa Base Editing Market Revenue (US$ Million) Estimates and Forecasts by Product & Service, 2024-2031
10.5.2. Middle East & Africa Base Editing Market Revenue (US$ Million) Estimates and Forecasts by End User, 2024-2031
10.5.3. Middle East & Africa Base Editing Market Revenue (US$ Million) Estimates and Forecasts by Type, 2024-2031
10.5.4. Middle East & Africa Base Editing Market Revenue (US$ Million) Estimates and Forecasts by Targeted base, 2024-2031
10.5.5. Middle East & Africa Base Editing Market Revenue (US$ Million) Estimates and Forecasts by Application, 2024-2031
10.5.6. Middle East & Africa Base Editing Market Revenue (US$ Million) Estimates and Forecasts by country, 2024-2031

Chapter 11. Competitive Landscape
11.1. Major Mergers and Acquisitions/Strategic Alliances
11.2. Company Profiles

11.2.1. Addgene
11.2.2. Base Therapeutics
11.2.3. Beam Therapeutics
11.2.4. Bio Palette Co., Ltd
11.2.5. Cellectis
11.2.6. Creative Biogene
11.2.7. Danaher Corporation
11.2.8. EdiGene, Inc.
11.2.9. ElevateBio
11.2.10. GenKOre
11.2.11. GenScript
11.2.12. Horizon Discovery Group plc.
11.2.13. HuidaGene Therapeutics
11.2.14. Intellia Therapeutics, Inc.
11.2.15. KromaTiD, Inc.
11.2.16. Maravai LifeSciences
11.2.17. Merck KGaA
11.2.18. Pairwise
11.2.19. ProQR Therapeutics
11.2.20. QI-Biodesign
11.2.21. Revvity
11.2.22. Shape TX
11.2.23. Synthego
11.2.24. Verve Therapeutics, Inc.
11.2.25. Other Prominent Players

Segmentation of Base Editing Market-

Base Editing Market By Product & Services

  • By Product
    • Platform
    • Reagents & Kits
    • Plasmids
    • Base Editing Libraries
  • By Service
    • gRNA Design
    • Cell Line Engineering
    • Other Services

base editing

Base Editing Market By Type

  • DNA Base Editing
  • RNA Base Editing

Base Editing Market By Targeted Base

  • Cytosine Base Editing
  • Adenine Base Editing

Base Editing Market By Application

  • Drug Discovery & Development
  • Agriculture
  • Veterinary

Base Editing Market By End User

  • Pharmaceutical & Biotechnology Companies
  • Academic & Research Institutes
  • Contract Research Organizations

Base Editing Market By Region-

North America-

  • The US
  • Canada
  • Mexico

Europe-

  • Germany
  • The UK
  • France
  • Italy
  • Spain
  • Rest of Europe

Asia-Pacific-

  • China
  • Japan
  • India
  • South Korea
  • Southeast Asia
  • Rest of Asia Pacific

Latin America-

  • Brazil
  • Argentina
  • Rest of Latin America

 Middle East & Africa-

  • GCC Countries
  • South Africa
  • Rest of the Middle East and Africa

 

InsightAce Analytic follows a standard and comprehensive market research methodology focused on offering the most accurate and precise market insights. The methods followed for all our market research studies include three significant steps – primary research, secondary research, and data modeling and analysis - to derive the current market size and forecast it over the forecast period. In this study, these three steps were used iteratively to generate valid data points (minimum deviation), which were cross-validated through multiple approaches mentioned below in the data modeling section.

Through secondary research methods, information on the market under study, its peer, and the parent market was collected. This information was then entered into data models. The resulted data points and insights were then validated by primary participants.

Based on additional insights from these primary participants, more directional efforts were put into doing secondary research and optimize data models. This process was repeated till all data models used in the study produced similar results (with minimum deviation). This way, this iterative process was able to generate the most accurate market numbers and qualitative insights.

Secondary research

The secondary research sources that are typically mentioned to include, but are not limited to:

  • Company websites, financial reports, annual reports, investor presentations, broker reports, and SEC filings.
  • External and internal proprietary databases, regulatory databases, and relevant patent analysis
  • Statistical databases, National government documents, and market reports
  • Press releases, news articles, and webcasts specific to the companies operating in the market

The paid sources for secondary research like Factiva, OneSource, Hoovers, and Statista

Primary Research:

Primary research involves telephonic interviews, e-mail interactions, as well as face-to-face interviews for each market, category, segment, and subsegment across geographies

The contributors who typically take part in such a course include, but are not limited to: 

  • Industry participants: CEOs, CBO, CMO, VPs, marketing/ type managers, corporate strategy managers, and national sales managers, technical personnel, purchasing managers, resellers, and distributors.
  • Outside experts: Valuation experts, Investment bankers, research analysts specializing in specific markets
  • Key opinion leaders (KOLs) specializing in unique areas corresponding to various industry verticals
  • End-users: Vary mainly depending upon the market

Data Modeling and Analysis:

In the iterative process (mentioned above), data models received inputs from primary as well as secondary sources. But analysts working on these models were the key. They used their extensive knowledge and experience about industry and topic to make changes and fine-tuning these models as per the product/service under study.

The standard data models used while studying this market were the top-down and bottom-up approaches and the company shares analysis model. However, other methods were also used along with these – which were specific to the industry and product/service under study.

 

user icon
office icon
mail icon
call icon

This website is secure, and we do not share your personal information with any third party. Privacy Policy

Need Customization
Need specific information/chapter from the report of the custom data table, graph or complete report? Tell us more.

Frequently Asked Questions

How big is the Base Editing Market Size?

The Base Editing Market is estimated to grow at a 16.4% CAGR during the forecast period for 2024-2031.

Danaher Corporation, Merck KgaA, Revvity, Maravai LifeSciences, GenScript, Beam Therapeutics, Intellia Therapeutics, Inc., Cellectis, Bio Palette Co.,

Our Clients

  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo

Media Citations

  • media citation logo
  • media citation logo
  • media citation logo
  • media citation logo
  • media citation logo
  • media citation logo
  • media citation logo
  • media citation logo
  • media citation logo

Growth opportunities and latent adjacency in Pharmaceuticals

Report License Selection

Determine the appropriate license for your report

Get Your GTM Strategy

Navigate market entry with channel selection, launch strategy & timeline, and pricing model support.

Equip yourself with the insights needed to develop a winning go-to-market strategy

Get real-time updates and joint control over project direction with our collaborative approach